Free Trial

GE HealthCare Technologies (GEHC) Stock Forecast & Price Target

GE HealthCare Technologies logo
$71.84 +0.83 (+1.17%)
Closing price 04:00 PM Eastern
Extended Trading
$71.91 +0.07 (+0.10%)
As of 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

GE HealthCare Technologies - Analysts' Recommendations and Stock Price Forecast (2025)

Consensus Rating

Sell
0
Hold
6
Buy
6

Based on 12 Wall Street analysts who have issued ratings for GE HealthCare Technologies in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 12 analysts, 6 have given a hold rating, and 6 have given a buy rating for GEHC.

Consensus Price Target

$85.20
18.60% Upside
According to the 12 analysts' twelve-month price targets for GE HealthCare Technologies, the average price target is $85.20. The highest price target for GEHC is $103.00, while the lowest price target for GEHC is $73.00. The average price target represents a forecasted upside of 18.60% from the current price of $71.84.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for GEHC and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for GE HealthCare Technologies and its competitors.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

GEHC Analyst Ratings Over Time

TypeCurrent Forecast
10/13/24 to 10/13/25
1 Month Ago
9/13/24 to 9/13/25
3 Months Ago
7/15/24 to 7/15/25
1 Year Ago
10/14/23 to 10/13/24
Strong Buy
0 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
Buy
6 Buy rating(s)
8 Buy rating(s)
8 Buy rating(s)
7 Buy rating(s)
Hold
6 Hold rating(s)
2 Hold rating(s)
3 Hold rating(s)
5 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$85.20$88.40$88.55$94.23
Forecasted Upside18.60% Upside15.65% Upside19.03% Upside3.52% Upside
Consensus RatingModerate BuyModerate BuyModerate BuyModerate Buy

GEHC Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

GEHC Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

GE HealthCare Technologies Stock vs. The Competition

TypeGE HealthCare TechnologiesMedical CompaniesS&P 500
Consensus Rating Score
2.50
2.33
2.52
Consensus RatingModerate BuyHoldModerate Buy
Predicted Upside18.60% Upside1,030.14% Upside14.05% Upside
News Sentiment Rating
Positive News

See Recent GEHC News
Positive News
Positive News
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
10/7/2025Citigroup
3 of 5 stars
Joanne Wuensch
Joanne Wuensch
4 of 5 stars
DowngradeBuyNeutral$93.00 ➝ $83.00+8.62%
9/29/2025Zacks Research
0 of 5 stars
 DowngradeStrong-BuyHold
9/27/2025Weiss Ratings
0 of 5 stars
 Reiterated RatingHold (C)
9/18/2025Morgan Stanley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Target$74.00-1.02%
7/14/2025BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Reiterated RatingBuy
5/5/2025UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSellNeutral$74.00 ➝ $73.00+3.50%
5/1/2025The Goldman Sachs Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower TargetBuy$94.00 ➝ $82.00+19.42%
5/1/2025Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower TargetOverweight$103.00 ➝ $89.00+29.06%
5/1/2025Evercore ISI
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower TargetOutperform$96.00 ➝ $85.00+22.20%
4/23/2025Piper Sandler
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Lower TargetOverweight$104.00 ➝ $88.00+35.41%
1/8/2025Jefferies Financial Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 UpgradeHoldBuy$95.00 ➝ $103.00+23.55%
9/30/2024Stifel Nicolaus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Boost TargetBuy$100.00 ➝ $102.00+10.88%
9/9/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Initiated CoverageNeutral$90.00+5.77%
8/1/2024Redburn Atlantic
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeStrong-Buy
5/1/2024Bank of America
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Lower TargetNeutral$94.00 ➝ $86.00+10.45%
5/1/2024Mizuho
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Lower TargetBuy$110.00 ➝ $105.00+35.45%
4/1/2024Argus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Boost TargetBuy$80.00 ➝ $110.00+22.82%
2/15/2024HSBC
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Initiated CoverageBuy$100.00+20.24%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 12:33 AM ET.


Should I Buy GE HealthCare Technologies Stock? GEHC Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, October 13, 2025. Please send any questions or comments about these GE HealthCare Technologies pros and cons to contact@marketbeat.com.

GE HealthCare Technologies
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in GE HealthCare Technologies Inc.:

  • The company recently reported earnings per share (EPS) of $1.06, exceeding analysts' expectations, which indicates strong financial performance and potential for growth.
  • GE HealthCare Technologies Inc. has a solid return on equity of approximately 23.93%, suggesting effective management and profitability relative to shareholder equity.
  • With a quarterly revenue of around $5 billion, the company has shown a revenue increase of 3.5% compared to the same quarter last year, reflecting a positive growth trend.
  • The current stock price is around $86.89, which is considered attractive given the company's strong fundamentals and growth potential.
  • Analysts have a consensus rating of "Moderate Buy" for the stock, with several upgrades indicating confidence in the company's future performance.

GE HealthCare Technologies
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in GE HealthCare Technologies Inc. for these reasons:

  • Despite recent positive earnings, some analysts have downgraded their ratings, indicating potential concerns about future performance.
  • The dividend yield is relatively low at 0.2%, which may not be attractive for income-focused investors.
  • Market volatility and economic uncertainties could impact the healthcare sector, potentially affecting GE HealthCare Technologies Inc.'s stock performance.
  • Some analysts have set target prices below the current stock price, suggesting that the stock may be overvalued in the short term.
  • The company's payout ratio is low at 2.87%, which may indicate limited room for dividend growth in the future.

GEHC Forecast - Frequently Asked Questions

According to the research reports of 12 Wall Street equities research analysts, the average twelve-month stock price forecast for GE HealthCare Technologies is $85.20, with a high forecast of $103.00 and a low forecast of $73.00.

12 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for GE HealthCare Technologies in the last year. There are currently 6 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" GEHC shares.

According to analysts, GE HealthCare Technologies's stock has a predicted upside of 18.60% based on their 12-month stock forecasts.

Over the previous 90 days, GE HealthCare Technologies's stock had 2 downgrades and 1 upgrade by analysts.

GE HealthCare Technologies has been rated by research analysts at Barclays, BTIG Research, Citigroup, Morgan Stanley, Weiss Ratings, and Zacks Research in the past 90 days.

Analysts like GE HealthCare Technologies more than other "medical" companies. The consensus rating for GE HealthCare Technologies is Moderate Buy while the average consensus rating for "medical" companies is Hold. Learn more on how GEHC compares to other companies.


This page (NASDAQ:GEHC) was last updated on 10/13/2025 by MarketBeat.com Staff
From Our Partners